Aimovig and Elmiron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aimovig (erenumab-aooe) and Elmiron (pentosan polysulfate sodium). Common drug interactions include maculopathy among females.

The phase IV clinical study analyzes what interactions people have when they take Aimovig and Elmiron. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Aimovig?

Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 49,930 Aimovig users. Check the latest studies of Aimovig.

What is Elmiron?

Elmiron has active ingredients of pentosan polysulfate sodium. It is often used in interstitial cystitis (ic). eHealthMe is studying from 10,215 Elmiron users. Check the latest studies of Elmiron.

On Jul, 08, 2026

21 people who take Aimovig and Elmiron together, and have interactions are studied.

What are the common drug interactions of Aimovig and Elmiron, by gender? *:

female:

Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
Age-related macular degeneration
Nausea (feeling of having an urge to vomit)
Panic attack
Chorioretinal scar (an area of pigmentary change in eye)
Abdominal discomfort
Abdominal pain upper
Alopecia (absence of hair from areas of the body)
Anxiety
Arthralgia (joint pain)

male:

n/a

What are the common drug interactions of Aimovig and Elmiron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
Age-related macular degeneration
Retinopathy (acute damage to the retina of the eye)
Drug ineffective
Hepatic enzyme increased
Chorioretinal scar (an area of pigmentary change in eye)
Macular degeneration (painless eye condition that leads to the gradual loss of central vision)

40-49:

Abdominal pain upper
Alopecia (absence of hair from areas of the body)
Anxiety
Arthralgia (joint pain)
Asthenia (weakness)
Back pain
Cataract (clouding of the lens inside the eye)
Constipation
Cough
Disturbance in attention

50-59:

Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
Depression
Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
Retinal pigmentation (pigmentation of retina)

60+:

Deafness
Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
Retinal deposits
Retinal pigment epitheliopathy (disease of pigment epithelium)
Tinnitus (a ringing in the ears)

What are the existing conditions these people have? *

Migraine (headache): 13 people, 61.90%
Cystitis Interstitial (unknown cause characterized by bladder pain): 12 people, 57.14%
Stress And Anxiety: 4 people, 19.05%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 19.05%
Nausea (feeling of having an urge to vomit): 4 people, 19.05%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 19.05%
Multiple Allergies (allergy to multiple agents): 4 people, 19.05%
Dizziness: 3 people, 14.29%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 14.29%
Bladder Disorder: 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Aimovig and Elmiron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously